There is unmet healthcare need for a single drug with a dual action which single-handedly can control the dyslipidemia and provide glycemic benefits without side-effects. Pankaj Patel, Chairman and MD, Zydus Cadila in an exclusive interview with Ananya Sen answers all you wanted to know about Lipaglyn.
Nick was appointed as CFO for dmg events in April 2015. Prior to his appointment, Nick worked in a number of roles within dmg events, playing an integral part in the development of the company portfolio via acquisition disposal and organic growth.
Nick is a member of the ICAEW, qualifying with the London office of Arthur Andersen. He is a graduate of St Catharine’s College, Cambridge University, graduating with an MA in Economics.
